23 Jul, 2026
According to Straits Research the global point-of-care molecular diagnostics market size was valued at $8.69 billion in 2025 and is expected to grow from $9.20 billion in 2026 to $14.92 billion by 2034, registering a CAGR of 6.23% during the forecast period 2026–2034.
The rising need for faster and accurate results from molecular tests and the increasing number of clinical studies to determine the efficiency and accuracy of novel molecular tests propel market growth.
sales@straitsresearch.com